StockData
BETRFOTCPharmaceutical PreparationsFiscal year ends January 31

BetterLife Pharma Inc.

Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)

Close on Oct 19, 2026

Market cap
$22.36M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

BetterLife Pharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements BetterLife Pharma filed with the SEC